Susan Swindells MBBS
Professor and Medical Director, HIV Clinic
Department of Internal Medicine
University of Nebraska Medical Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: More than one quarter of the world’s population is infected with tuberculosis (TB), and there is effective treatment for this but only a small fraction of those eligible actually receive it. TB is the leading cause of death for people with HIV infection, globally. One of the major problems with currently available treatments for TB infection is that they take too long, and people just stop taking them after a while. We identified an ultra-short course of treatment (only one month) and tested it against the conventional 6-month course of treatment.
Our main findings were that the new short course was just as effective as the standard 6 month course, more patients taking the short course completed their treatment, and had less adverse effects.Continue reading →
Dr. Hongying Dai, PhD
Associate Professor at the College of Public Health
University of Nebraska Medical Center.
MedicalResearch.com: What is the background for this study?
Response: The 2009 Family Smoking Prevention and Tobacco Control Act (FSPTCA) banned cigarettes with characterizing flavors (e.g., candy, fruit, clove) except menthol. However, there are no restrictions on the marketing and sales of flavored non-cigarette tobacco products. This has led to a proliferation of flavored tobacco products in the marketplace. Flavoring has become one of the leading reasons for current tobacco use among youth. It is reported that 81% of e-cigarette users, 79% of hookah users, 74% of cigar users, 69% of smokeless tobacco users, and 67% of snus users attributed the availability of appealing flavors for their tobacco use in 2013–2014 among teenagers aged 12 to 17 years. In November 2018, the FDA proposed new restrictions on flavored tobacco products.